Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

20/10/2026

Tipologie di procedimenti - aggiornamento sezione

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

20/10/2026

Newsletter trimestrale Medicina di Genere – ottobre 2026

Agendas and minutes

20/10/2026

Agenda - European Medicines Agency workshop on bacteriophage therapy

Consumer Updates RSS Feed

05/10/2026

Advisory Committees Give FDA Critical Advice and the Public a Voice

Regulatory and procedural guidelines (human and veterinary)

20/10/2026

Recommended submission dates for veterinary medicinal products

Scientific guidelines (human and veterinary)

19/10/2026

Reflection paper on methodological aspects in confirmatory platform trials

Paediatric investigation plans

14/10/2026

Opinion/decision on a Paediatric investigation plan (PIP): Opdualag, nivolumab,relatlimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0169/2024

Orphan designations

07/10/2026

Orphan designation: somapacitan Treatment of growth hormone deficiency, 24/08/2018 Withdrawn

New medicines and opinions: human

16/10/2026

Human medicines European public assessment report (EPAR): Fovlussea, ranibizumab, Ophthalmologicals, Status: Opinion

MedWatch Safety Alerts RSS Feed

20/10/2026

Early Alert: Cardinal Health Updates Use Instructions for Presource Packs Containing BD Alaris Pump Infusion Sets

What's New: Drugs RSS Feed

20/10/2026

Novel Drug Approvals for 2026

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis